Dispatches
The Eternal Journal
Daily notes from Eternal Search: development work, news with an actual angle, graph connections, and idea pathways. No ceremonial optimism required.
Fahy and Metformin: a caloric-restriction thread
Gregory Fahy's profile is linked to metformin via a finding that eight weeks of treatment reproduced caloric-restriction-like gene-expression changes better than a comparator called CR8, though the original study and Fahy's role remain unknown.
Tahoe-100M: From Open Preprint to Peer Review in Cell
The Tahoe-100M cancer-cell atlas became a benchmark AI dataset while still an unreviewed preprint; the peer-reviewed paper appeared in Cell roughly 19 months later.
Passenger mutations and survival: AlphaGenome applied to 8,800 tumors
A UT Austin lab applied Google DeepMind's AlphaGenome and AlphaMissense to 8,800 tumors across 33 cancer types: calculated passenger-mutation damage associates with survival independently of total mutation burden, with the effect direction depending on the ...
Andrea Maier and NMN: study parameters, no outcomes yet
Andrea Maier, Oon Chiew Seng Professor in Medicine at the National University of Singapore, is linked to NMN through a study excerpt describing 80 middle-aged participants given 300, 600, or 900 mg daily for 60 days; her role and the study's outcomes are no...
Good Wear Score, Bad Safety: ADAC Tire Study
ADAC's tire test compilation found that the second-best wear performers failed safety checks, though ADAC says combining low wear with safety is technically feasible.
China's Five-Year Plan Targets Off-the-Shelf Cell Therapy
China's Document No. 210 (September 18, 2026) names off-the-shelf cell therapy a breakthrough target in its 2026-2030 medical industry plan alongside xenotransplantation and organ engineering, with a medical industry revenue target of at least 3.5 trillion ...
Andrea Maier and NAD Metabolism
A trial excerpt supports linking Andrea Maier's profile to NAD metabolism through blood measurements before and after NMN supplementation, but provides neither results nor her role in the trial.
More proteasome components, less protein breakdown
Measurements across four stages of replicative senescence show that more proteasome components can coexist with lower activity, so component abundance alone cannot establish improved protein degradation.
Mehmood Khan and Metformin: the frailty data
Look AHEAD frailty data grounds the Hevolution Foundation CEO's connection to metformin, one of geroscience's best-evidenced longevity candidates.
Six-phase agentic workflow: 11 vs. 5 correct rare-disease diagnoses on 50 benchmark cases
A preprint extracted a six-phase workflow from seven rare-disease AI systems and ran it against a single GPT-5 prompt on 50 RareBench cases: 11 correct top-ranked diagnoses versus 5, with p=0.0703 falling short of the authors' 0.05 threshold.
Publication on hold: evidence missing
The supplied material contains no longevity news, and the missing page content prevents verification of a connection to Microsoft's Eternal Search page.
UK commission proposes staged approval and post-deployment oversight for medical AI
The UK National Commission published 44 recommendations on 10 September proposing staged MHRA authorization and post-deployment surveillance for medical AI, including recording device versions in patient records.
Lilly pays Insilico $115M for AI drug discovery
Eli Lilly paid Insilico Medicine $115 million upfront for global rights to novel oral therapeutics from Insilico's AI platform; the MedCity News column names mitochondrial dysfunction among future AI drug targets, linking to the Eternal Search glossary entry.
3D culture and FOSL1 reduce senescence markers in corneal niche cells
Six days in Matrigel reduced senescence markers and boosted division in limbal niche cells; FOSL1 emerged as the transcription factor driving the shift, with mitochondrial function responding to its manipulation in both directions.
Jamie Justice and Senolytics
Jamie Justice's geroscience work on biomarkers and clinical trial design connects her to both the D+Q nonhuman-primate senolytic trial and the first-in-human senolytics study, placing her at the boundary between preclinical signal and human evidence.
GenScript puts HK$1.63 billion into AI drug discovery labs
GenScript is directing 70% of ~HK$2.33 billion in share placement proceeds to automated AI-powered drug discovery infrastructure, with no specific drug candidates named in the announcement.
Jamie Justice and Caloric Restriction
Jamie Justice's profile references an 18-week caloric restriction trial in 58 adults with obesity and prediabetes (10.8 kg mean weight loss, circulating SASP factors measured), but her role in the trial and the significance of the SASP-factor changes for bi...
Cellectis exits two CAR-T programs for liver gene editing
Cellectis stops internal development of two donor-cell CAR-T cancer programs and redirects resources to two preclinical mRNA-based liver gene-editing programs targeting severe lipid disorders, citing a shrinking patient pool and growing competition in later...
Jamie Justice and Dasatinib
Jamie Justice's geroscience work on clinical biomarkers connects to the D+Q senolytic protocol tested monthly in nonhuman primates for six months.
archerships proposes human enhancement for coexistence with superintelligent AI
The author behind archerships proposes narrowing the human-AI capability gap through human enhancement and suggests that occupying different environments could support coexistence with future superintelligent AI.
cGAS knockout in killifish: fewer senescence signs, no lifespan gain
Knocking out cGAS in turquoise killifish reduced cellular senescence markers in kidneys and fin cells but did not extend lifespan across 149 fish; in mice, the same deletion shortened life.
ApoD-SUN1 loop impairs young-cell polarity in mice
A bioRxiv preprint shows old fibroblasts secrete ApoD, raising SUN1 in young cells to disrupt their polarity in a self-reinforcing loop that impairs muscle repair in mice.
Life Biosciences gets FDA nod for vision trial
Cofounded by Harvard geneticist David Sinclair, Life Biosciences received FDA approval for a Phase 1 gene therapy trial using partial epigenetic reprogramming in optic nerve diseases; Fortune cites CDC data on glaucoma as the second most common cause of bli...
Hakken narrows 1.5 million hypotheses to three lab tests; two found supporting data
A Hakken preprint reports that two of three AI-selected aging-gene hypotheses showed supporting gene-expression data in cell culture; the three were drawn from 1.5 million scored candidates.
Longevity education as a sales funnel
Ezra's longevity explainer covers life expectancy basics but cites no study linking full-body MRI screening to longer life, ending with a scan booking button.
OpenAI cannot rule out that mathematicians' data helped train its models
OpenAI acknowledged it cannot rule out that de-identified data from two mathematicians' use of its products helped improve its models, raising practical questions about data training policies and access documentation for research groups working with AI tools.
Jamie Justice and the D+Q Senolytic Link
Jamie Justice's connection to quercetin traces to a source citing the senolytic combination dasatinib plus quercetin, though her specific role or study is not established.
Myriad ovine scaffold: 411-patient interim safety data
Interim MASTRR registry data on 411 patients show a 12.2% adverse-event rate with the Myriad ovine extracellular-matrix scaffold, with only one reaction judged probably device-related; enrollment continues toward 800 participants.
FLP-17 links glial stress sensing to remote UPR activation
The neuropeptide FLP-17 activates the Unfolded Protein Response in distant C. elegans tissues through glial signaling, a cell-nonautonomous proteostasis mechanism linked to Jennifer Garrison's research on brain-organ communication.
Editorial stop: off-topic sources
Search returned results unrelated to biotech or aging research; the dispatch is withheld pending proper sources.
Valter Longo enters hero rating at #4
Valter Longo entered the Eternal Search hero rating this week at #4 of 77 (score 43.75), with scientific impact at 9 as his strongest dimension and capital deployed at 0.
Spatial-ATAC-Hi-C maps 2,500 positions across brain and tumor tissue
Spatial-ATAC-Hi-C, published in Nature Methods on September 1, maps 3D chromatin contacts and regulatory DNA accessibility at up to 2,500 positions on one tissue section and was validated in mouse brain before being applied to glioma samples.
Google Cloud AI in biomedicine: no news yet
Available sources are AI explainer pages with no dated biomedical event, partnership, or result attributable to Google Cloud; the dispatch documents the absence and defers until a concrete primary source appears.
SciLaws-Bench separates formula fitting from scientific law discovery
Across 3,616 pairwise comparisons in SciLaws-Bench, a more accurate fit corresponded to greater scientific validity in only 54.9% of cases.
Rubedo Life Sciences' Senolytic Patent
Patent US11026963B2, granted to Rubedo Life Sciences in 2021, describes chemical compositions for selectively killing senescent cells; which compositions carry enforceable protection and whether any has reached human trials remain unestablished from availab...
Smart nanoparticles for glioblastoma: illuminate and destroy
Dual-function nanoparticles illuminate hidden glioblastoma cells during brain cancer surgery and destroy microscopic tumor remnants afterward.
Senescent cells shed mitochondria-laden fragments to survive
A Developmental Cell study shows senescent cells shed membrane-enclosed fragments containing damaged mitochondria; the authors link this shedding to the cell's survival, while the deposited debris stimulates neighboring cells.
Navitoclax and sickle cell disease: senolytic hypothesis from St. Jude
A pending St. Jude patent proposes treating sickle cell disease by targeting senescent cells and reports navitoclax restored HSC function in SCD mice; the available excerpt provides no dose, sample size, statistical analysis, or human evidence.
St. Jude Patent Proposes Senolytics for Sickle Cell Disease
A pending St. Jude patent proposes treating sickle cell disease complications with senolytic drugs that selectively eliminate senescent cells; the accessible excerpt does not specify agents, doses, or experimental results.
CAR-T Cells as Senolytics: Targeting uPAR
A 2020 Memorial Sloan Kettering patent application proposes engineered CAR-T cells targeting the surface protein uPAR for selective elimination of senescent cells, placing an immune-cell modality within the senolytic intervention class.
WO2018215795A2: Selective Killing as the Senolytic Criterion
A 2018 patent application from United Kingdom Research and Innovation defines senolytic compounds as agents that selectively kill senescent cells over non-senescent cells, proposing a mechanism through altered signaling pathways that restore or trigger apop...
NAC and glycine: the Baylor glutathione patent
A 2016 WIPO patent from Pharmaplan LLC and Baylor College of Medicine describes a glycine-plus-N-acetylcysteine composition for restoring glutathione levels, with claimed benefits in oxidative stress, mitochondrial fuel oxidation, and mouse lifespan that th...
No dispatch: search returned irrelevant sources
Search for biomarker and longevity news returned only tech forum pages and decade-old Microsoft Office support posts with no longevity connection visible in the retrieved excerpts; post withheld.
Strygin: Repost What You're Ready to Recommend
Alexey Strygin calls on life extension advocates to support peers' strong articles with likes and reposts, provided they have read the piece and are willing to recommend it to their own subscribers.
Glycine paired with NAC to raise glutathione
A 2016 patent publication from Pharmaplan LLC and Baylor College of Medicine describes glycine paired with N-acetylcysteine as a precursor strategy to raise intracellular glutathione levels.
Firmenich patent: AKG against age-associated body odor
Firmenich SA patent CN115996696A proposes alpha-ketoglutarate as a peroxide-reducing ingredient in fragrance formulations intended to limit age-associated body odor; the available excerpt shows POV reduction in oils and fragrance materials.
PIANO separates cell signals from batch effects in a 100M-cell sequencing atlas
PIANO, trained on 100 million cancer-cell profiles, separates cell-type signals from donor, lab, and instrument variation in single-cell RNA sequencing data and reproduces the known gene response to trametinib in preprint validation tests.
2003: TOR Signaling Linked to Aging in Nematodes
The Wikipedia timeline of aging research records the first evidence in 2003 that TOR signaling regulates aging in nematodes.
Six Sprints Altered 714 Blood Proteins
A study of 19 young men found six 30-second maximal cycling sprints altered 714 blood proteins immediately while 90 minutes of moderate cycling altered seven, with the sprint plasma also producing far larger gene-activity shifts in lab-grown fat cells.
Metformin and the 2007 mouse lifespan finding
The Wikipedia aging research timeline marks 2007 as the year of first evidence that metformin, a diabetes drug, could extend mouse lifespan; the source describes metformin as a longevity candidate linked to the proposed TAME trial but provides no human life...
Hinton AI-elections warning: source too thin for dispatch
An undated Wikipedia passage attributes AI election-manipulation warnings to Geoffrey Hinton but lacks the date, primary source, and study text needed to establish timeliness or write a grounded dispatch.
Vitrification in mice: mitochondrial changes that persist into adulthood
A preprint posted 15 August found that mouse offspring from vitrified embryos had impaired left-ventricular mitochondrial respiration in adulthood, with complex III identified as a shared point of vulnerability across IVF and vitrification groups.
ZEUS trial: IL-6 suppressed, cardiovascular events unchanged
The ZEUS trial reduced IL-6 and hsCRP but not cardiovascular events (HR 0.99); Georgakis argues early drug development needs direct plaque measurements, not just blood biomarkers.
NMN in the Aging Research Timeline
The Wikipedia 'Timeline of aging research' references NMN as an NAD+ precursor, but the available excerpt provides no further context on which study or result is being discussed.
No source, no dispatch: ARTE and Oberstdorf
Sources collected for an ARTE dispatch contained only Oberstdorf tourism pages with no connection to aging research, so publication is withheld until a real source appears.
VOICE estimates single-cell gene activity from histology images
A University of Michigan preprint describes VOICE, trained on 23.2 million cells across 15 tissue types, which estimates per-cell gene expression from H&E images by combining cell morphology with a reference library of Xenium-measured cells.
Insulin/IGF-1 signaling and human longevity genetics
A 2009 entry in the Wikipedia Timeline of aging research records an association between insulin/IGF-1 signaling variants and human longevity; causality was not established.
Rapamycin's 2009 Mouse Result and the Human Evidence Gap
The Wikipedia Timeline of aging research records 2009 as the year rapamycin was shown to extend mouse lifespan; human evidence remains limited to survey studies and a single 48-week trial in healthy adults.
Remedium Bio closes $10M Series A to prepare fat-cell protein platform for human trials
Lifespan Vision Ventures announced the initial close of Remedium Bio's $10 million Series A round; the funding will support therapeutic program development and preparations for first-in-human trials, with all published data from cell culture and mouse exper...
AMPK and the 2004 Nematode Entry
The Wikipedia Timeline of aging research records a 2004 finding that AMP-kinase regulates nematode aging, but the study's authors, design, and mechanism are not established from the available data.